Yeom, Chan-Woo
(Department of Neuropsychiatry, Eulji General Hospital, Eulji University School of Medicine)
Eun, Tae-Kyung (Department of Neuropsychiatry, Eulji General Hospital, Eulji University School of Medicine) Park, Hoon-Sub (Department of Neuropsychiatry, Eulji General Hospital, Eulji University School of Medicine) Lee, Kyu-Young (Department of Neuropsychiatry, Eulji General Hospital, Eulji University School of Medicine) Kim, Eui-Joong (Department of Neuropsychiatry, Eulji General Hospital, Eulji University School of Medicine) Joo, Eun-Jeong (Department of Neuropsychiatry, Eulji General Hospital, Eulji University School of Medicine) Koo, Young-Jin (Department of Child and Adolescent Psychiatry, Eulji General Hospital, Eulji University School of Medicine) |
1 | American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association;2013. |
2 | Yang SJ, Cheong S, Hong SD. Prevalence and correlates of attention deficit hyperactivity disorder: school-based mental health services in Seoul. J Korean Neuropsychiatr Assoc 2006;45:69-76. 과학기술학회마을 |
3 | Yoo HJ, Yang SJ, Shin D, Kang H, Kim BN, Kim JH, et al. The Korean practice parameter for the treatment of attention-deficit hyperactivity disorder (III): pharmacologic treatment. J Korean Acad Child Adolesc Psychiatry 2007;18:16-25. 과학기술학회마을 |
4 | Safer DJ, Allen RP, Barr E. Growth rebound after termination of stimulant drugs. J Pediatr 1975;86:113-116. DOI |
5 | Loney J, Whaley-Klahn MA, Ponto LB, Adney K. Predictors of adolescent height and weight in hyperkinetic boys treated with methylphenidate [proceedings]. Psychopharmacol Bull 1981;17:132-134. |
6 | Mattes JA, Gittelman R. Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry 1983;40: 317-321. DOI |
7 | Satterfield JH, Cantwell DP, Satterfield BT. Multimodality treatment. A one-year follow-up of 84 hyperactive boys. Arch Gen Psychiatry 1979;36:965-974. DOI |
8 | MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004;113:762- 769. DOI ScienceOn |
9 | Spencer TJ, Biederman J, Harding M, O’Donnell D, Faraone SV, Wilens TE. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 1996;35:1460-1469. DOI ScienceOn |
10 | Biederman J, Spencer TJ, Monuteaux MC, Faraone SV. A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects. J Pediatr 2010;157:635-640, 640.e1. DOI ScienceOn |
11 | Spencer TJ, Kratochvil CJ, Sangal RB, Saylor KE, Bailey CE, Dunn DW, et al. Effects of atomoxetine on growth in children with attention- deficit/hyperactivity disorder following up to five years of treatment. J Child Adolesc Psychopharmacol 2007;17:689-700. DOI ScienceOn |
12 | Rogol AD, Roemmich JN, Clark PA. Growth at puberty. J Adolesc Health 2002;31(6 Suppl):192-200. DOI ScienceOn |
13 | Korean Academy of Child and Adolescent Psychiatry. Adolescent Psychiatry. Seoul: Sigma Press;2012. p.16-24. |
14 | Bereket A, Turan S, Karaman MG, Haklar G, Ozbay F, Yazgan MY. Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment. Horm Res 2005;63:159-164. DOI ScienceOn |
15 | Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, et al. European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 2011; 20:17-37. DOI ScienceOn |
16 | Korea Center for Disease Control and Prevention, The Committee for the Development of Growth Standard for Korean Children and Adolescents. 2007 Korean Children and Adolescents Growth Standard. Available from URL: http://www.cdc.go.kr. |
17 | Spencer TJ, Faraone SV, Biederman J, Lerner M, Cooper KM, Zimmerman B, et al. Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD? J Am Acad Child Adolesc Psychiatry 2006;45:527-537. DOI ScienceOn |
18 | Kim HW, Ko BJ, Park TW, Shin YO, Lee JS, Chung US, et al. Safety and tolerability of OROS methylphenidate for the treatment of ADHD. J Korean Acad Child Adolesc Psychiatry 2012;23 (Suppl):S24-S45. |
19 | Pliszka SR, Matthews TL, Braslow KJ, Watson MA. Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2006;45:520-526. DOI ScienceOn |
20 | Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-723. DOI ScienceOn |